Get the Stockscreener App
48.25
12.02%
-6.59
After Hours:
47.75
-0.50
-1.04%
Inspire Medical Systems Inc stock is traded at $48.25, with a volume of 4.49M.
It is down -12.02% in the last 24 hours and down -12.26% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
See More
Previous Close:
$54.84
Open:
$47
24h Volume:
4.49M
Relative Volume:
3.78
Market Cap:
$1.39B
Revenue:
$911.98M
Net Income/Loss:
$145.42M
P/E Ratio:
9.7196
EPS:
4.9642
Net Cash Flow:
$78.48M
1W Performance:
-12.45%
1M Performance:
-12.26%
6M Performance:
-41.74%
1Y Performance:
-69.60%
1-Day Range:
$44.41
$48.38
1-Week Range:
$44.41
$57.91
52-Week Range:
$44.41
$163.35
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
48.25 | 1.58B | 911.98M | 145.42M | 78.48M | 4.9642 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-12-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip (NYSE:INSP) - Seeking Alpha
Inspire Medical Shareholders Approve Board Declassification and Governance Changes - TipRanks
Investors back new equity plan and board changes at Inspire Medical (NYSE: INSP) - Stock Titan
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - TradingView
Inspire Medical Systems Faces Limited Visibility, RBC Says - marketscreener.com
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down - Yahoo Finance UK
Stifel cuts Inspire Medical stock price target on weak guidance By Investing.com - Investing.com Canada
Inspire Medical Systems Q1 2026 earnings preview - MSN
Piper Sandler Downgrades Inspire Medical Systems to Neutral From Overweight, $85 Price Target - Moomoo
Inspire Medical Systems stock hits 52-week low at $45.00 - Investing.com
Inspire Medical Systems Sees 2026 EPS 7c-EPS 62c >INSP - Moomoo
Inspire Medical Systems, Inc. Reports Q1 2026 Financial Results and Forward-Looking Statements - Minichart
Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED) - Benzinga
Truist Securities Adjusts Price Target on Inspire Medical Systems to $50 From $64, Maintains Hold Rating - marketscreener.com
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2026 Earnings Call Transcript - Insider Monkey
BofA cuts Inspire Medical stock rating on reimbursement concerns By Investing.com - Investing.com Canada
Mizuho cuts Inspire Medical Systems stock price target on guidance reduction - Investing.com Canada
Inspire Medical Systems 1Q Adj EPS 10c >INSP - Moomoo
Inspire Medical Systems (INSP) Q1 earnings and revenues top estimates - MSN
INSP Q1 Deep Dive: Coding Headwinds and WISER Program Drive Down Full-Year Outlook - TradingView
Inspire Medical Q1 2026 slides: strong earnings beat masks growth slowdown - Investing.com Canada
Inspire Medical Systems Earnings Preview: Revenue Expected Flat - IndexBox
Inspire Medical Systems, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
INSP: 2026 revenue guidance cut to $825–$875M due to reimbursement and WISeR headwinds - TradingView
Earnings call transcript: Inspire Medical beats Q1 2026 EPS forecasts By Investing.com - Investing.com South Africa
Inspire Medical Systems Sees 2026 Adj EPS 75c-Adj EPS $1.25 >INSP - Moomoo
Inspire (INSP) Q1 2026 Earnings Call Transcript - The Globe and Mail
Director at Inspire Medical (INSP) granted 3,562 RSUs - Stock Titan
Inspire Medical Systems (INSP) grants 3,562 RSUs to board director - Stock Titan
Inspire Medical (INSP) director receives 3,562-share RSU award - Stock Titan
Director at Inspire Medical (INSP) receives 3,562 RSU equity award - Stock Titan
Director Cynthia Burks receives 3,562 RSUs at Inspire Medical (INSP) - Stock Titan
Director Shelley G. Broader granted 3,562 RSUs at Inspire Medical (INSP) - Stock Titan
Full Transcript: Inspire Medical Systems Q1 2026 Earnings Call - Benzinga
Inspire Medical Systems (INSP) director receives 3,562 RSUs in equity grant - Stock Titan
Inspire Medical Systems (INSP) director gets 3,562 RSUs and 50-share tax withholding - Stock Titan
Earnings call transcript: Inspire Medical beats Q1 2026 EPS forecasts - Investing.com
Inspire (INSP) Reports Q1 Earnings: What Key Metrics Have to Say - Yahoo Finance
Inspire Medical Systems (INSP) Q1 Earnings and Revenues Top Estimates - Yahoo Finance
Inspire Medical Cuts 2026 Outlook Amid Reimbursement Headwinds - TipRanks
Inspire Medical Systems Q1 Adjusted Earnings Flat, Revenue Rises; Lowers Full-Year Guidance - marketscreener.com
(INSP) Inspire Medical Systems Now Expects Full Year 2026 Revenue Range $825M$875M, vs. FactSet Est of $961.9M - marketscreener.com
Inspire Medical : First Quarter 2026 Earnings Presentation - marketscreener.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Q1 2026 Inspire Medical Systems Inc Earnings Call Transcript - GuruFocus
Inspire Medical Systems (NYSE:INSP) Q1 Earnings Beat on Profit But Revenue Miss Sends Stock Plummeting - ChartMill
Inspire Medical slashes 2026 guidance amid reimbursement uncertainty - MassDevice
Inspire: Q1 Earnings Snapshot - marketscreener.com
Earnings Flash (INSP) Inspire Medical Systems, Inc. Posts Q1 Adjusted EPS $0.10 per Share - marketscreener.com
Inspire Medical Systems’s (NYSE:INSP) Q1 CY2026 Sales Top Estimates But Stock Drops 18.8% - Yahoo! Finance Canada
[10-Q] Inspire Medical Systems, Inc. Quarterly Earnings Report - Stock Titan
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):